Karen Eubanks Jackson has reshaped the conversation around breast cancer for Black women in America—and now, with the ASCO ...

Cervical cancer prevention advances with new immunotherapy findings, addressing disparities and improving outcomes for ...

Adding subcutaneous sasanlimab to BCG improved recurrence-free survival in non–muscle-invasive bladder cancer, according to Dr. Petros Grivas.

Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

The study adds to growing evidence that digital tools can maximize genetic counselors' limited time without patient harm.